Sandy Cove Advisors, LLC - SQZ BIOTECHNOLOGIES CO ownership

SQZ BIOTECHNOLOGIES CO's ticker is SQZ and the CUSIP is 78472W104. A total of 37 filers reported holding SQZ BIOTECHNOLOGIES CO in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Sandy Cove Advisors, LLC ownership history of SQZ BIOTECHNOLOGIES CO
ValueSharesWeighting
Q2 2023$13,961
-51.8%
51,7070.0%0.01%
-61.9%
Q1 2023$28,956
-24.3%
51,7070.0%0.02%
-32.3%
Q4 2022$38,263
-67.6%
51,7070.0%0.03%
-70.8%
Q3 2022$118,000
-28.0%
51,7070.0%0.11%
-28.9%
Q2 2022$164,000
-34.1%
51,7070.0%0.15%
-28.0%
Q1 2022$249,000
-46.1%
51,7070.0%0.21%
-46.8%
Q4 2021$462,00051,7070.39%
Other shareholders
SQZ BIOTECHNOLOGIES CO shareholders Q4 2022
NameSharesValueWeighting ↓
Artal Group S.A. 1,606,309$9000.05%
Sandy Cove Advisors, LLC 51,707$28,9560.02%
MAVERICK CAPITAL LTD 1,051,771$588,9920.02%
Temasek Holdings (Private) Ltd 2,758,169$1,544,5750.01%
AMERICAN INTERNATIONAL GROUP, INC. 2,517,173$1,409,6170.01%
RBF Capital, LLC 74,674$41,8170.00%
Laurion Capital Management LP 431,400$241,5840.00%
Baldrige Asset Management LLC 5,000$30.00%
STIFEL FINANCIAL CORP 874,326$489,6220.00%
Bangor Savings Bank 11,357$6,3600.00%
View complete list of SQZ BIOTECHNOLOGIES CO shareholders